A Cobalt Schiff-Base Complex as a Putative Therapeutic for Azide Poisoning

Area of Science:

• Toxicology
• Coordination Chemistry
• Pharmacology

Background:

• Azide poisoning lacks a specific antidote.
• Schiff-base cobalt complexes are explored for therapeutic applications.

Purpose of the Study:

• To investigate the potential of Co(II)-2,12-dimethyl-3,7,11,17-tetraazabicyclo-[11.3.1]heptadeca-1(17)2,11,13,15-pentaenyl dibromide (Co(II)N4[11.3.1]) as an antidote for azide toxicity.
• To elucidate the mechanism of azide binding to the cobalt complex.

Main Methods:

• Stopped-flow kinetics were used to study azide binding to Co(II)N4[11.3.1] in the absence of oxygen.
• The effect of the cobalt complex on azide intoxication was evaluated in a mouse model.

Main Results:

• Azide binding to Co(II)N4[11.3.1] occurred in three phases, with the major process showing second-order rate constants of 29 M⁻¹s⁻¹ at 25°C and 70 M⁻¹s⁻¹ at 37°C.
• The binding reaction was pH-independent around neutrality, indicating the azide anion is the reactive species.
• Administration of Co(II)N4[11.3.1] significantly reduced righting-recovery times in mice and prevented 100% knockdown observed in control groups.

Conclusions:

• Co(II)N4[11.3.1] demonstrates protective effects against azide intoxication in vivo.
• Despite a complex binding mechanism, this cobalt complex shows promise as a potential therapeutic agent for azide poisoning.